Experts Forecast 2024, Part 3: Precision Medicine for Cancer Treatment
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts on precision medicine.
Progress Against Cancer
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts on precision medicine.
Study shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving cancer treatment in their community.
Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to labels for CAR T-cell therapies.
AACR will host the inaugural Blood Cancer Discovery Symposium March 4-6, 2024, featuring experts from all areas of blood cancer research.
Non-invasive scanning for biomarkers after only 1 week may guide treatment for some patients with melanoma and avoid surgery in other patients. Imaging may help determine if the immunotherapeutic pembrolizumab (Keytruda) is helping patients with...
Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.
January is Cervical Cancer Awareness Month. Here's the latest on prevention, screening, and treatment.
In part 2 of our 2024 Experts Forecast, Robert A. Winn, MD, FAACR, discusses ways to achieve health equity.
Hiding serious illness can be a coping strategy, and cancer rates are on the rise among young people.
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful discussions, and plenty of networking.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More